Home > Quotes > ESCA > Guru Analysis > Kenneth Fisher

Kenneth Fisher Guru Analysis for Escalade, Incorporated

ESCA 
$16.34
*  
0.20
1.21%
Get ESCA Alerts
*Delayed - data as of Jul. 25, 2014 10:34 ET  -  Find a broker to begin trading ESCA now
Exchange: NASDAQ
Industry: Consumer Non-Durables
Community Rating:
View:    ESCA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Assessments & Analysis Based on July 24, 2014 close price: $16.54

  for the Price/Sales Investor based on the criteria of Kenneth Fisher. Return to ESCA Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 91%
Benjamin Graham 43%
Validea 71%
Motley Fool 59%
David Dreman 21%
Martin Zweig 54%
Kenneth Fisher 80%
James P. O'Shaughnessy 50%



Detailed Analysis

Guru Score: 80%


PRICE/SALES RATIO: [PASS]

The prospective company should have a low Price/Sales ratio. Non-cyclical (non-Smokestack) companies with Price/Sales ratio between .75 and 1.5 are good values. ESCA's P/S ratio of 1.38 Based on trailing 12 month sales, falls within the "good values" range for non-cyclical companies and is considered attractive.


TOTAL DEBT/EQUITY RATIO: [PASS]

Less debt equals less risk according to this methodology. ESCA's Debt/Equity of 22.19% is acceptable, thus passing the test.


PRICE/RESEARCH RATIO: [PASS]

This methodology considers companies in the Technology and Medical sectors to be attractive if they have low Price/Research ratios. ESCA is neither a Technology nor Medical company. Therefore the Price/Research ratio is not available and, hence, not much emphasis should be placed on this particular variable.


PRELIMINARY GRADE: Some Interest in ESCA At this Point

Is ESCA a "Super Stock"? NO


PRICE/SALES RATIO: [FAIL]

The prospective company should have a low Price/Sales ratio. Smokestack(cyclical) companies with Price/Sales ratios greater than .8 are considered extremely unattractive and should even be sold according to this methodology. ESCA's P/S ratio of 1.38 exceeds the acceptable level for cyclical industries.


LONG-TERM EPS GROWTH RATE: [PASS]

This methodology looks for companies that have an inflation adjusted EPS growth rate greater than 15%. ESCA's inflation adjusted EPS growth rate of 32.35% passes the test.


FREE CASH PER SHARE: [PASS]

This methodology looks for companies that have a positive free cash per share. Companies should have enough free cash available to sustain three years of losses. This is based on the premise that companies without cash will soon be out of business. ESCA's free cash per share of 0.10 passes this criterion.


THREE YEAR AVERAGE NET PROFIT MARGIN: [FAIL]

This methodology looks for companies that have an average net profit margin of 5% or greater over a three year period. ESCA, whose three year net profit margin averages 1.99%, fails this evaluation.


 
The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer